(bloomberg)
(ANSA) — The United States health agency this Monday (23) made official the definitive authorization for the use of an anti-Covid vaccine developed by the Biotech/Pfizer consortium.
Until that time, immunization agents from a German laboratory and an American multinational were used with emergency permits in the US.
The authorization given by the Food and Medicine Administration (FDA) for the application of the vaccine to people 16 years of age or older comes at a time when the vaccination campaign against COVID-19 is showing signs of stagnation in the country. .
“The FDA’s approval of this vaccine is a milestone as we battle the pandemic,” agency commissioner Janet Woodcock said in a press statement. “While millions of people have had anti-Covid vaccines, we believe that for some, FDA approval may give them more confidence to vaccinate,” he said.
according to portal our world in dataNearly 60% of the United States population took at least one dose of vaccines against the new coronavirus, a number comparable to Brazil, which launched its campaign nearly two months later.
The free course teaches stock exchange sustainability to earn and monetize capital. take part!
